Kim Alexander Papp
0000-0001-9557-3642
Publication & Citation Trends
Publications
0 total
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials OA
Cited by 0
Semantic Scholar
72091 SPECTREM: Guselkumab Skin Clearance and Patient-Reported Outcome Results Across Skin and Joint Symptoms Through Week 48 in Low Body Surface Area, Moderate Plaque Psoriasis With at Least One Moderate High-Impact Site Involved
Cited by 0
Semantic Scholar
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study OA
Cited by 0
Semantic Scholar
Approach to the Assessment and Management of Adult Patients With Prurigo Nodularis: A Canadian Consensus OA
Cited by 0
Semantic Scholar
Efficacy and Safety of CT‐P43, a Candidate Ustekinumab Biosimilar, in Moderate‐to‐Severe Plaque Psoriasis: 52‐Week Results From a Randomised, Active‐Controlled, Double‐Blind, Phase III Study OA
Cited by 0
Semantic Scholar
72909 Bimekizumab durability of response through 4 years in patients with plaque psoriasis who stopped and re-started treatment
Cited by 0
Semantic Scholar
Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis OA
Cited by 3
Semantic Scholar
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary. OA
Cited by 1
Semantic Scholar
Research Topics
Psoriasis: Treatment and Pathogenesis
(593)
Dermatology and Skin Diseases
(308)
Spondyloarthritis Studies and Treatments
(258)
Rheumatoid Arthritis Research and Therapies
(85)
Pharmaceutical studies and practices
(78)
Affiliations
Northwestern University
Goethe University Frankfurt
University of Rome Tor Vergata
University of Southern California
Poznan University of Medical Sciences
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.